Regional nodal staging for early stage colon cancer in the era of endoscopic resection and N.O.T.E.S.
Advanced endoscopic technologies and techniques capable of providing localized resection of colonic primaries are entering clinical practice. As much as Natural Orifice Transluminal Endoscopic Surgery (N.O.T.E.S.) may ultimately provide for transmural resection with narrow margins, intraluminal techniques such as endoscopic submucosal resection can now effect excision of early stage tumors from within the colon. However, the limit on the application of these approaches is oncological providence as current staging requires en bloc mesenteric resection in every case to ensure that adequate nodal assessment is assured. Furthermore, this requirement is also a limiting factor on the advance of innovative procedures such as Single-Incision Laparoscopic Surgery and N.O.T.E.S.-hybrid techniques as these approaches, while likely adept at the definitive management of the primary, have limitations regarding their ability to provide full base mesenteric resection (due mostly to constraints on retraction capacity as well as operating field space and exposure). Therefore a means to accurately and efficiently identify those patients who are truly node negative (and so in whom radical mesenteric lymphadenectomy could be avoided) would allow all of these techniques to advance with a clear focus on address of the primary. This review analyses the current state of the art of regional staging in the colonic mesentery in place of formal lymphadenectomy. It includes deliberation of both preoperative non-invasive testing as well as novel means of employing N.O.T.E.S. approaches to allow direct determination of lymph node status (in particular that of sentinel nodes) by either rapid histopathological examination or by emerging technologies such as Optical Coherence Tomography that may provide optical or 'virtual' biopsy.
Cahill
R A
RA
Department of Colorectal Surgery, John Radcliffe Hospital, Oxford, United Kingdom; European Institute of Surgical Research and Innovation (EISRI), Dublin, Ireland. cahillra@gmail.com
D003110:Colonic Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000556:secondary / Q000601:surgery*; D016145:Endoscopy, Digestive System / Q000295:instrumentation / Q000379:methods* / Q000639:trends; D006801:Humans; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging / Q000295:instrumentation / Q000379:methods*; D011859:Radiography; D021701:Sentinel Lymph Node Biopsy / Q000379:methods